Removing arbitrary limitations on buprenorphine for opioid use disorder.  Gastala, N., Hudak, B., Pho, M.T., Pollack, H.A. and Wilcox, K. (2025),  Addiction, 120: 1913-1915. doi.org/10.1111/add.70127 https://onlinelibrary.wiley.com/doi/…

Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experience.  Lowry N, McKechnie A, Day E, Gilvarry E, Cowden F, Evans R, et al.  Addiction. 2025; …

Addiction: Volume 120, Issue 10 - Pages: 1909-2158 -October 2025 https://onlinelibrary.wiley.com/toc/13600443/2025/120/10

Recognition and Management of Iatrogenically Induced Opioid Dependence and Withdrawal in Children: Clinical Report. Adam C. Adler, Linda B. Siegel, Robert T. Wilder, Julie Good, Committee on Drugs, Section on Critical Care…

Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process.  Donroe JH, Calcaterra SL, Simon C, et al.  JAMA Netw Open. 2025;8(8):e2528703. doi:10.1001/jamanetworkopen.2025.28703 https://jamanetwor…

Daily profiles of nondrug reward and their association with daily outcomes for people in recovery from opioid use disorder: An application of latent profile analysis applied to intensive longitudinal data.  Stull SW, Marsch LA, Lanza ST. …